Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

NCT07072676 is registered in ClinicalTrials.gov with LMU Klinikum as lead sponsor.

NCT NCT07072676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07072676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.
Lead sponsor
LMU Klinikum
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 1, 2025
Completion date
August 1, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammatory demyelinating polyneuropathy, facio-scapulo-humeral dystrophy, friedreich ataxia, guillain barré syndrome, hereditary motor and sensory neuropathies, inclusion body myositis, lambert eaton (lems), limb girdle muscular dystrophies, myasthaenia gravis, myotonic dystrophy 1, myotonic dystrophy 2, pompe disease (infantile-onset), spinal muscular atrophy (sma)